Stago Connect.One Network Allows Remote Monitoring of Analyzers
By Labmedica International staff writers
09 Aug 2018
Diagnostica Stago (Paris, France), an in-vitro diagnostics company focusing on thrombosis and hemostasis, has launched the secure Connect.One network architecture, which allows laboratories to benefit from remote monitoring of their automated analyzers.
Stago offers laboratories advanced testing systems and services with specialization in hemostasis and hemostasis systems, in-vitro diagnostics, routine and specialty reagents, and research products. Digitization has revolutionized connectivity by increasing productivity and improving lab efficiency. Today, with connected devices, technical teams are no longer required to remain in front of their workstations, or even in the laboratory.
Stago’s Connect.One checks if automated analyzers in laboratories are operating correctly and diagnoses and analyzes any malfunctions as part of a proactive approach. Systems connected to Connect.One can send QC results to MyExpertQC (Stago’s externalized IQC platform), as well as activity statistics to simplify the management of “Cost Per Reportable Results” contracts. Connect.One can track analyzer performance and send notifications in case of problems while downloading software improvements from a secure infrastructure.
Connect.One is designed to meet international data privacy and security guidelines, and is expected to become a “cornerstone” for integrating new applications. By using their connected devices, laboratories can increase productivity, efficiency and operational flexibility.